Clinical Trial: Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial
Brief Summary: A single-centered, randomized, controlled clinical trial comparing standardized medical care alone with standardized medical care and decompressive hemicraniectomy to determine the effectiveness of decompressive surgery more definitively in patients with clinical signs of infarction of the Middle Carotid Artery (MCA) territory.
Detailed Summary: A single-centered, randomized, controlled clinical trial comparing standardized medical care alone with standardized medical care and decompressive hemicraniectomy to determine the effectiveness of decompressive surgery more definitively in patients with clinical signs of infarction of the MCA territory and and who arrived at the hospital within 72 hours of symptom onset.
Sponsor: University of the Philippines
Current Primary Outcome: Functional status measured by modified Rankin Score (mRS) [ Time Frame: up to six months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Survival measured by modified Rankin Score (mRS) [ Time Frame: up to six months ]
Original Secondary Outcome: Same as current
Information By: University of the Philippines
Dates:
Date Received: November 7, 2013
Date Started: January 2002
Date Completion:
Last Updated: February 16, 2014
Last Verified: February 2014